Navigation Links
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
Date:4/1/2008

cells and thereby prevent viral replication, which occurs within the cells. CCR5 is also a receptor for chemokines, members of a family of protein molecules that are secreted by cells as part of the body's natural inflammatory response. Unlike small- molecule CCR5 antagonists, PRO 140 inhibits HIV entry at concentrations that in vitro do not appear to block CCR5's natural function, which includes, in part, directing the migration of immune cells towards sites of inflammation in the body.

About Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward gastroenterology as well as the treatment of HIV infection and cancer. The Company, in collaboration with Wyeth, is developing methylnaltrexone for the treatment of opioid-induced side effects, including constipation (oral and subcutaneous formulations) and post-operative ileus (intravenous formulation). In March 2007, the Company submitted a New Drug Application to the United States Food and Drug Administration for the subcutaneous formulation of methylnaltrexone for patients suffering from opioid-induced constipation while receiving palliative care, followed in May 2007 by Wyeth's submission of a Marketing Authorization Application (MAA) in Europe to the European Medicines Agency (EMEA). In the area of HIV infection, the Company is developing the viral-entry inhibitor PRO 140, a humanized monoclonal antibody targeting the HIV entry co-receptor CCR5, which has completed phase 1b clinical studies with positive results. In the area of prostate cancer, the Company is developing a human monoclonal antibody drug conjugate -- a selectively targeted cytotoxic antibody directed against prostate-specific membrane antigen (PSMA), a pro
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium
2. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
3. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
8. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
9. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
10. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  IQPC,s 19 th ... announce the chairman of the Summit Mr. Phani Bidarahalli ... will be joined by the expert speaker faculty including senior ... May 11 – 12, at The Hotel Kabuki in ... is available for download on the event website, which can ...
(Date:5/5/2015)...  Accuray Incorporated (Nasdaq: ARAY ), announced today that ... America Merrill Lynch 2015 Healthcare Conference in ... at 2:20pm PT.   A live webcast ... Relations page of the Company,s website at http://www.accuray.com/investors ... approximately one hour after the conclusion of the live ...
(Date:5/5/2015)... , May 5, 2015  Image Stream Medical, ... new agreement with MedAssets, one of the largest group ... the United States.  Under terms of the three-year agreement, ... and services will be made available to MedAssets members ... the partnership, Image Stream Medical CEO Eddie Mitchell ...
Breaking Medicine Technology:Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2Image Stream Medical Announces Agreement with MedAssets 2
... (NYSE: PFE ) announced today it is ... myeloid leukemia (CML) based on data from a clinical ... treated patients.  These regulatory submissions are planned for 2011. ... has begun the process of preparing a Marketing Authorization ...
... 3, 2010 US Oncology, Inc ., the nation,s ... with US Oncology Research participated in studies that ... Hematology ( ASH ) Annual Meeting and Exposition at the ... other investigators in the US Oncology Research Network participated in ...
Cached Medicine Technology:Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 2Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 3Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 4Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia 5US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 2US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 3US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition 4
(Date:5/5/2015)... The brains of people with type 1 ... slower information processing, according to research led by the ... . , The findings indicate that clinicians should ... cognitive difficulties. If progressive, these changes could influence their ... the National Institutes of Health (NIH), is ...
(Date:5/5/2015)... California (PRWEB) May 05, 2015 On ... Downtown Los Angeles, CA, Choices Recovery sponsored Durkin Entertainment’s ... Durkin, LA’s leading producer of sustainable product placement in ... of the world’s top providers of ecologically sound and ... a premier red carpet event that makes appearances at ...
(Date:5/5/2015)... What do you get when you combine ... greatest mountaineers and one of the world’s greatest causes? The ... documentary by Marc Middleton, which follows world-renowned mountaineer Chris Warner ... 19,341-foot frozen summit of Mount Kilimanjaro. , “This film ... to action. Viewers are moved to ask, ‘What can I ...
(Date:5/5/2015)... 05, 2015 Buckeye Health Plan (BHP) ... CEO and plan president of Buckeye Health Plan. Hill, ... position immediately. , Hill has more than 28 years ... Pacific Northwest, from managed care to large health care ... CEO of HealthPlus of Michigan, a health plan serving ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... leadership guidebook called “Medicare Breakeven Challenges? A ... guidebook includes:, ,     Formulas for ... aren’t measuring but should be , ... unproductive “white space” and ensures sustained efficient ...
Breaking Medicine News(10 mins):Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 3Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2
... , , , INDIANAPOLIS, ... District of Indiana today upheld Eli Lilly and Company,s (NYSE: ... tablets). In the case of Eli Lilly and Company ... favor of Lilly on all accounts for these method-of-use patents, ...
... , , SAN FRANCISCO, ... a leader in the development, manufacturing and sales of products ... disease, said today that the two-year results of the Fractional ... confirm the importance of FFR in improving patient outcomes and ...
... and communication can alleviate the psychological distress and burnout ... University of Rochester Medical Center researchers report in today,s ... Association ( JAMA ). The training also ... and enhance patient-centered care, according to the researchers, who ...
... , , , ... today that the organization,s mail-in pharmacy benefits ranked highest in ... National Pharmacy Study(SM). The study measured more than a ... across five factors: ordering convenience, delivery convenience, medication availability and ...
... building in Congress ... empowering small dollar ... Elections Now Coalition, which represents seven national campaign reform organizations, today praised Rep. Peter DeFazio ... cosponsoring the bipartisan Fair Elections Now Act, H.R. 1826. , , The ...
... , CHICAGO, Sept. 23 , , Study 1 highlights : ... blood pressure in men. , A drug used to treat gout seems to ... Study 2 highlights : , , A study ... blood pressure, weight gain and behavior. , , , ...
Cached Medicine News:Health News:U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014 2Health News:U.S. District Court Upholds Validity of Lilly's Evista Patents Through 2014 3Health News:Volcano Corporation Praises FAME Study Results 2Health News:Volcano Corporation Praises FAME Study Results 3Health News:Volcano Corporation Praises FAME Study Results 4Health News:Volcano Corporation Praises FAME Study Results 5Health News:Mindful meditation, shared dialogues reduce physician burnout 2Health News:Mindful meditation, shared dialogues reduce physician burnout 3Health News:Mindful meditation, shared dialogues reduce physician burnout 4Health News:Kaiser Permanente Recognized by J.D. Power and Associates as Highest in Customer Satisfaction Among Mail-Order Pharmacies 2Health News:Kaiser Permanente Recognized by J.D. Power and Associates as Highest in Customer Satisfaction Among Mail-Order Pharmacies 3Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 2Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 3Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 4Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 5Health News:American Heart Association Meeting Report: High-Sugar Diet Increases Men's Blood Pressure; Gout Drug Protective 6
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only....
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... The Self-Cath Closed System is ... a method for safe, simple catheterization ... urinary tract infections. It includes ... The new EasyOff tear tab ...
Medicine Products: